Chilton Capital Management’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $258K | Sell |
10,735
-6,000
| -36% | -$157K | 0.01% | 207 |
|
|
2026
Q1 | $470K | Buy |
16,735
+277
| +2% | +$7.38K | 0.02% | 175 |
|
|
2025
Q4 | $410K | Sell |
16,458
-63,537
| -79% | -$1.6M | 0.01% | 177 |
|
|
2025
Q3 | $2.04M | Buy |
79,995
+15,738
| +24% | +$388K | 0.07% | 104 |
|
|
2025
Q2 | $1.56M | Sell |
64,257
-1,138
| -2% | -$26.5K | 0.06% | 109 |
|
|
2025
Q1 | $1.66M | Sell |
65,395
-1,197
| -2% | -$31.3K | 0.07% | 103 |
|
|
2024
Q4 | $1.77M | Sell |
66,592
-3,134
| -4% | -$85K | 0.07% | 103 |
|
|
2024
Q3 | $2.02M | Buy |
69,726
+804
| +1% | +$23.5K | 0.08% | 100 |
|
|
2024
Q2 | $1.93M | Sell |
68,922
-934
| -1% | -$25.7K | 0.09% | 100 |
|
|
2024
Q1 | $1.94M | Sell |
69,856
-6,888
| -9% | -$191K | 0.09% | 100 |
|
|
2023
Q4 | $2.21M | Sell |
76,744
-21,250
| -22% | -$642K | 0.11% | 100 |
|
|
2023
Q3 | $3.25M | Sell |
97,994
-1,373
| -1% | -$48.6K | 0.18% | 85 |
|
|
2023
Q2 | $3.64M | Buy |
99,367
+522
| +0.5% | +$20.3K | 0.2% | 80 |
|
|
2023
Q1 | $4.03M | Buy |
98,845
+2,148
| +2% | +$92.8K | 0.23% | 80 |
|
|
2022
Q4 | $4.95M | Sell |
96,697
-1,495
| -2% | -$71.7K | 0.31% | 77 |
|
|
2022
Q3 | $4.3M | Buy |
98,192
+4,676
| +5% | +$227K | 0.29% | 78 |
|
|
2022
Q2 | $4.9M | Buy |
93,516
+5,652
| +6% | +$288K | 0.3% | 76 |
|
|
2022
Q1 | $4.55M | Buy |
87,864
+46
| +0.1% | +$2.39K | 0.24% | 80 |
|
|
2021
Q4 | $5.19M | Sell |
87,818
-353
| -0.4% | -$17.5K | 0.26% | 79 |
|
|
2021
Q3 | $3.79M | Buy |
88,171
+8,762
| +11% | +$388K | 0.21% | 87 |
|
|
2021
Q2 | $3.11M | Buy |
79,409
+65,777
| +483% | +$2.56M | 0.18% | 90 |
|
|
2021
Q1 | $494K | Buy |
13,632
+3,636
| +36% | +$129K | 0.03% | 146 |
|
|
2020
Q4 | $368K | Sell |
9,996
-793
| -7% | -$29.1K | 0.03% | 152 |
|
|
2020
Q3 | $376K | Sell |
10,789
-303
| -3% | -$10.6K | 0.03% | 151 |
|
|
2020
Q2 | $344K | Sell |
11,092
-4,420
| -28% | -$150K | 0.03% | 152 |
|
|
2020
Q1 | $480K | Sell |
15,512
-527
| -3% | -$18K | 0.05% | 135 |
|
|
2019
Q4 | $596K | Hold |
16,039
| – | – | 0.05% | 150 |
|
|
2019
Q3 | $547K | Sell |
16,039
-184
| -1% | -$6.69K | 0.05% | 151 |
|
|
2019
Q2 | $667K | Sell |
16,223
-1,322
| -8% | -$52.5K | 0.06% | 138 |
|
|
2019
Q1 | $707K | Buy |
17,545
+539
| +3% | +$21.6K | 0.06% | 136 |
|
|
2018
Q4 | $704K | Sell |
17,006
-5,270
| -24% | -$219K | 0.07% | 140 |
|
|
2018
Q3 | $931K | Sell |
22,276
-1,611
| -7% | -$62K | 0.08% | 140 |
|
|
2018
Q2 | $822K | Sell |
23,887
-3,149
| -12% | -$108K | 0.07% | 145 |
|
|
2018
Q1 | $910K | Sell |
27,036
-32,776
| -55% | -$1.13M | 0.08% | 137 |
|
|
2017
Q4 | $2.06M | Sell |
59,812
-13,966
| -19% | -$476K | 0.19% | 86 |
|
|
2017
Q3 | $2.5M | Sell |
73,778
-15,241
| -17% | -$490K | 0.24% | 84 |
|
|
2017
Q2 | $2.84M | Sell |
89,019
-198,374
| -69% | -$6.26M | 0.31% | 77 |
|
|
2017
Q1 | $9.33M | Buy |
287,393
+2,994
| +1% | +$94.4K | 0.93% | 47 |
|
|
2016
Q4 | $8.76M | Buy |
284,399
+1,147
| +0.4% | +$35K | 0.92% | 50 |
|
|
2016
Q3 | $9.1M | Buy |
283,252
+6,246
| +2% | +$209K | 0.92% | 50 |
|
|
2016
Q2 | $9.25M | Buy |
277,006
+46,359
| +20% | +$1.48M | 0.9% | 51 |
|
|
2016
Q1 | $6.49M | Buy |
230,647
+24,134
| +12% | +$689K | 0.65% | 65 |
|
|
2015
Q4 | $6.33M | Buy |
206,513
+90,183
| +78% | +$2.84M | 0.66% | 65 |
|
|
2015
Q3 | $3.47M | Buy |
116,330
+85,256
| +274% | +$2.73M | 0.36% | 85 |
|
|
2015
Q2 | $989K | Sell |
31,074
-54
| -0.2% | -$1.76K | 0.09% | 114 |
|
|
2015
Q1 | $1.03M | Buy |
31,128
+360
| +1% | +$11.4K | 0.1% | 114 |
|
|
2014
Q4 | $909K | Buy |
30,768
+1,264
| +4% | +$36.2K | 0.09% | 122 |
|
|
2014
Q3 | $828K | Buy |
29,504
+3,053
| +12% | +$85.7K | 0.09% | 124 |
|
|
2014
Q2 | $745K | Sell |
26,451
-1,364
| -5% | -$38.9K | 0.07% | 129 |
|
|
2014
Q1 | $848K | Hold |
27,815
| – | – | 0.09% | 121 |
|
|
2013
Q4 | $808K | Sell |
27,815
-1,038
| -4% | -$30.2K | 0.09% | 128 |
|
|
2013
Q3 | $786K | Sell |
28,853
-1,107
| -4% | -$30.1K | 0.09% | 129 |
|
|
2013
Q2 | $796K | Buy |
+29,960
| New | +$828K | 0.1% | 129 |
|
Other funds holding PFE
Chilton Capital Management's PFE Position: Q2 2026 in Review
Chilton Capital Management reduced its Pfizer (PFE) stake by 36% in Q2 2026, selling an estimated $157K and leaving 10,735 shares worth $258K. The position accounts for 0.01% of the portfolio, ranked #207.
Chilton Capital Management first reported a position in PFE in Q2 2013 and has held it in 53 quarters since. The position peaked at $9.33M in Q1 2017. 2,823 funds tracked by Wall St. Rank hold PFE as of Q2 2026.
- Chilton Capital Management held 10,735 shares of Pfizer worth $258K as of Q2 2026.
- Chilton Capital Management sold 6,000 Pfizer shares in Q2 2026, an estimated $157K.
- Pfizer made up 0.01% of Chilton Capital Management's portfolio in Q2 2026, its #207 holding.
- Chilton Capital Management first reported a position in Pfizer in Q2 2013 and has held it in 53 quarters since.
- Chilton Capital Management's Pfizer position peaked at $9.33M in Q1 2017.
- 2,823 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.
Based on Chilton Capital Management's 13F filing for Q2 2026, filed 4 Aug 2026.